Issue 3 of the ERNICA newsletter is now available to read! Click here to access it!
The STEPS-EA trial is a multi-centre Randomised Controlled Trial looking at intralesional STEroid injections to Prevent refractory Strictures in patients with Esophageal Atresia. The trial involves 1:1 randomization to injection with 10 mg/ml TAC (Kenacort-A 10) prior to balloon dilatation and balloon dilatation without any injection. This is the first ERNICA randomized controlled trial and the trial team is excited to announce that they are now waiting for the first eligible patient to include. Click here for the first STEPS-EA trial newsletter which provides an update on progress so far! For any questions please email the The STEPS-EA trial team at email@example.com
The call for new members to join ERNICA is officially open! It will remain open until 30 November 2019. For more information on the call and to access all relevant documents please visit the European Commission’s ERN website: https://ec.europa.eu/health/ern/consultations/2019_call_membership_en The online application tool has now been activated and is ready for use! The launch of this call also marks the end of the designation period for affiliated partners. Those who have applied for affiliated partnership can also submit an application for full membership. Please get in touch if you have any queries.